JACC: CardioOncology,IF为:12分,排名第9; JACC-Cardiovascular Interventions,IF为:11.7分,排名第10; JACC-HEART FAILURE,IF为:10.3分,排名第11; JACC-Basic to Translational Science,IF为:8.4分,排名第15; JACC-Clinical Electrophysiology,IF为:8分,排名第17; 我们比较了JCR一区SCIE期刊的影响因子变化情况: 心...
11.3CiteScore 11.3Impact Factor Articles & Issues About PublishGuide for authors Journal Insights Aims & scope A Journal of the American College of Cardiology JACC: Cardiovascular Interventions is one of a family of specialist journals launched by the renowned Journal of the American College of Cardio...
Jacc-心血管干预(Jacc-cardiovascular Interventions)是一本由Elsevier Inc.出版的一本CARDIAC & CARDIOVASCULAR SYSTEMS学术刊物,主要报道CARDIAC & CARDIOVASCULAR SYSTEMS相关领域研究成果与实践。本刊已入选来源期刊,属于国际一流期刊。该刊创刊于2008年,出版周期Monthly。2021-2022年最新版WOS分区等级:Q1,2023年发布的影响...
近日,汤森路透公布了最新的《期刊引用报告(Journal Citation Reports)》。 纵观2017年医学领域的SCI期刊影响因子(Impact Factor, IF),CA - A CANCERJOURNAL FOR CLINICIANS依然傲居榜首,但IF飙升到了244.585;第二名为NEW ENGLAND JOURNAL OFMEDICINE,IF达到79.258;第三名由LANCET后来居上,IF为53.254。 表1 2017年SC...
of-the-art reviews from cardiology, cardiovascular surgery, neurology, outcomes research, and related fields are encouraged. Experimental and preclinical work that directly relates to diagnostic or therapeutic interventions are also encouraged. In general, case reports will not be considered for ...
paper to disclose.The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where ap...
JACC: Cardiovascular Interventionsis one of a family of specialist journals launched by the renownedJournal of the American College of Cardiology (JACC). It encompasses the entire field ofinterventional cardiovascular medicine, includingcardiac…
jacc: basic to translational science jacc: cardiooncology jacc: cardiovascular imaging jacc: cardiovascular interventions jacc: case reports jacc: clinical electrophysiology
Anatomic interventions for pulmonary vein stenosis (PVS) in infants and children have been met with limited success. Sirolimus, a mammalian target of rapamycin inhibitor, has demonstrated promise as a primary medical therapy for PVS, but ...
EditorialNo.07Timing of Valve Interventions in Patients With Chronic Aortic Regurgitation: Are We Waiting Too Long?慢性主动脉瓣反流患者瓣膜介入治疗的时机:我们等待太久了吗?03-04 21:51 | 10.1016/j.jacc.2018.11.061 Research ArticleNo.08Longitudinal Titration of Medical Therapy for Heart Failure with...